CAS RN: 133338-85-9
LITHIUM IONOPHORE VIII
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250305
50mg
In stock
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 133338-85-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
133338-85-9 / 2-[2,2-bis[[2-(dicyclohexylamino)-2-oxoethoxy]methyl]butoxy]-N,N-dicyclohexylacetamide
Standard CAS: 133338-85-9
Multi CAS: No
Basic Information
copy
CAS
133338-85-9 copy
Multi CAS
No copy
Molecular Formula
C48H83N3O6 copy
Molecular Weight
798.200000 copy
Exact Mass
797.628187 copy
SMILES
CCC(COCC(=O)N(C1CCCCC1)C2CCCCC2)(COCC(=O)N(C3CCCCC3)C4CCCCC4)COCC(=O)N(C5CCCCC5)C6CCCCC6 copy
InChI
InChI=1S/C48H83N3O6/c1-2-48(36-55-33-45(52)49(39-21-9-3-10-22-39)40-23-11-4-12-24-40,37-56-34-46(53)50(41-25-13-5-14-26-41)42-27-15-6-16-28-42)38-57-35-47(54)51(43-29-17-7-18-30-43)44-31-19-8-20-32-44/h39-44H,2-38H2,1H3 copy
InChIKey
QSTVDAZAPLNMPD-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
57 copy
Fraction Csp3
0.94 copy
Rotatable bonds
19 copy
H-bond acceptors
6 copy
Molar refractivity
226.96 copy
TPSA
88.62 copy
LogP / Solubility
WLOGP
9.91 copy
MLOGP
8.8 copy
XLogP3
10.2 copy
Consensus LogP
9.64 copy
Log S (ESOL)
-9.78 copy
Class (ESOL)
Insoluble copy
Log S (Ali)
-13.26 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-15.36 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-0.55 copy
Drug-likeness / Medicinal Chemistry
Lipinski
No copy
Ghose
No copy
Veber
No copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.17 copy
Leadlikeness
No copy
Synthetic Accessibility
5.5 copy
Safety & Transport
copy
GHS Hazard Statements
Not Classified
Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website. copy